Kelly-Spratt KS - Search Results

1

ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.

Busch SE, Moser RD, Gurley KE, Kelly-Spratt KS, Liggitt HD, Kemp CJ. Busch SE, et al. Among authors: kelly spratt ks. Oncogene. 2014 May 15;33(20):2665-73. doi: 10.1038/onc.2013.208. Epub 2013 Jun 10. Oncogene. 2014. PMID: 23752194 Free PMC article.

2

p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.

Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ. Ruddell A, et al. Oncogene. 2008 May 15;27(22):3145-55. doi: 10.1038/sj.onc.1210973. Epub 2007 Dec 3. Oncogene. 2008. PMID: 18059331

3

Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.

Kelly-Spratt KS, Philipp-Staheli J, Gurley KE, Hoon-Kim K, Knoblaugh S, Kemp CJ. Kelly-Spratt KS, et al. Oncogene. 2009 Oct 15;28(41):3652-62. doi: 10.1038/onc.2009.226. Epub 2009 Aug 3. Oncogene. 2009. PMID: 19648963 Free PMC article.

4

p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.

Kelly-Spratt KS, Gurley KE, Yasui Y, Kemp CJ. Kelly-Spratt KS, et al. PLoS Biol. 2004 Aug;2(8):E242. doi: 10.1371/journal.pbio.0020242. Epub 2004 Aug 17. PLoS Biol. 2004. PMID: 15314658 Free PMC article.

5

Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.

Ruddell A, Croft A, Kelly-Spratt K, Furuya M, Kemp CJ. Ruddell A, et al. BMC Cancer. 2014 May 21;14:354. doi: 10.1186/1471-2407-14-354. BMC Cancer. 2014. PMID: 24886322 Free PMC article.

6

Tumor suppression by p53 in the absence of Atm.

Bailey SL, Gurley KE, Hoon-Kim K, Kelly-Spratt KS, Kemp CJ. Bailey SL, et al. Mol Cancer Res. 2008 Jul;6(7):1185-92. doi: 10.1158/1541-7786.MCR-07-2009. Epub 2008 Jun 26. Mol Cancer Res. 2008. PMID: 18583527 Free PMC article.

7

Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.

Kelly-Spratt KS, Pitteri SJ, Gurley KE, Liggitt D, Chin A, Kennedy J, Wong CH, Zhang Q, Buson TB, Wang H, Hanash SM, Kemp CJ. Kelly-Spratt KS, et al. PLoS One. 2011 May 12;6(5):e19721. doi: 10.1371/journal.pone.0019721. PLoS One. 2011. PMID: 21589862 Free PMC article.

8

Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.

Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Buson TB, Chin A, Wang H, Zhang Q, Wong CH, Chodosh LA, Nelson PS, Hanash SM, Kemp CJ. Pitteri SJ, et al. Among authors: kelly spratt ks. Cancer Res. 2011 Aug 1;71(15):5090-100. doi: 10.1158/0008-5472.CAN-11-0568. Epub 2011 Jun 8. Cancer Res. 2011. PMID: 21653680 Free PMC article.

9

A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.

Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. Besson A, et al. Genes Dev. 2006 Jan 1;20(1):47-64. doi: 10.1101/gad.1384406. Genes Dev. 2006. PMID: 16391232 Free PMC article.

10

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM. Taguchi A, et al. Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007. Cancer Cell. 2011. PMID: 21907921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page